Ticker HubNasdaq

SENS

Senseonics Holdings, Inc. Common Stock

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL

Latest price

$7.67+2.13%

As of Oct 26, 2026, 7:28 PM EDT · Market data by Massive

Market cap

$397.1M

Volume

489.4K

Previous close

$7.51

Day range

$7.43 – $7.76

Listed

Mar 18, 2016

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $7.86Latest interval $7.67

Newsroom

Latest SENS coverage

BiotechDec 14, 2018

Sensorion’s vertigo drug hits tolerability endpoint in phase 2

[ad_1] A phase 2a trial of Sensorion’s vertigo seliforant has met its major tolerability endpoint. The trial discovered the histamine kind 4 receptor antagonist had no impact on vigilance and cognitive efficiency, suggesting it could have an edge over present vertigo remedies comparable to meclizine. Meclizine, a histamine H1 receptor antagonist, is used to

SENSFREEDAILYCNS

Company overview

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Industry: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Employees: 130
Headquarters: GERMANTOWN, MD
CIK: 0001616543

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Mar 18, 2016

Listed

130

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.